Adherence to osteoporosis pharmacotherapy is underestimated using days supply values in electronic pharmacy claims data

Pharmacoepidemiology and Drug Safety

Volumn 24, Issue 1, 2015, Pages 67-74

  Burden, Andrea M ^a   Paterson, J Michael ^b,d,e   Gruneir, Andrea ^b,c,d   Cadarette, Suzanne M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

Author keywords

Adherence; Days supply; Exposure misclassification; Pharmacoepidemiology; Pharmacy claims data

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; DENOSUMAB; ETIDRONIC ACID; RALOXIFENE; RISEDRONIC ACID; ZOLEDRONIC ACID; BONE DENSITY CONSERVATION AGENT;

AGED; ARTICLE; BONE DENSITY; COMMUNITY; FEMALE; GERIATRIC PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OSTEOPOROSIS; PATIENT COMPLIANCE; PHARMACY; PRIORITY JOURNAL; CANADA; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; FOLLOW UP; INSURANCE; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; ELECTRONIC HEALTH RECORDS; ELECTRONIC PRESCRIBING; FEMALE; FOLLOW-UP STUDIES; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICATION ADHERENCE; ONTARIO; OSTEOPOROSIS; PHARMACEUTICAL SERVICES;

EID: 84920895491     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3718     Document Type: Article

References (26)

1. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother 2005; 39: 319-328. doi:10.1345/aph.1E027.
2. Cramer JA, Gold DT, Silverman SL, Lewiecki EM. A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 2007; 18: 1023-1031. doi:10.1007/s00198-006-0322-8.
3. Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 2007; 82: 1493-1501. doi:10.1016/S0025-6196(11)61093-8.
4. Schneeweiss S, Avorn J. A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 2005; 58: 323-337. doi:10.1016/j.jclinepi.2004.10.012.
5. Levy AR, O'Brien BJ, Sellors C, Grootendorst P, Willison D. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10: 67-71.
6. Farris K, Kaplan B, Kirking DM. Examination of days supply in computerized prescription claims. J Pharmacoepidemiol 1994; 3: 63-76.
7. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec. J Clin Epidemiol 1995; 48: 999-1009.
8. Gross R, Bilker WB, Strom BL, Hennessy S. Validity and comparison of two measures of days supply in Medicaid claims data. Pharmacoepidemiol Drug Saf 2008; 17: 1029-1032. doi:10.1002/pds.1606.
9. Cadarette SM, Burden AM. Measuring and improving adherence to osteoporosis pharmacotherapy. Curr Opin Rheumatol 2010; 22: 397-403. doi:10.1097/BOR.0b013e32833ac7fe.
10. Burden AM, Huang A, Tadrous M, Cadarette SM. Variation in the days supply field for osteoporosis medications in Ontario. Arch Osteoporos 2013; 8: 128. doi:10.1007/s11657-013-0128-1.
11. Strom BL. Methodologic challenges to studying patient safety and comparative effectiveness. Med Care 2007; 45: S13-S15. doi:10.1097/MLR.0b013e318041f752.
12. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care 2006; 44: 471-477. doi:10.1097/01.mlr.0000207817.32496.cb.
13. Ministry of Health and Long-Term Care. The Ontario Drug Benefit Program - If you Travel. Available at: http://www.health.gov.on.ca/en/public/programs/drugs/programs/odb/opdp_travel_supply.aspx. Accessed March 24, 2014.
14. Jackevicius CA, Paterson JM, Naglie G. Concordance between discharge prescriptions and insurance claims in post-myocardial infarction patients. Pharmacoepidemiol Drug Saf 2007; 16: 207-215. doi:10.1002/pds.1289.
15. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10: 3-12. doi:10.1111/j.1524-4733.2006.00139.x.
16. Rabenda V, Mertens R, Fabri V, et al. Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. Osteoporos Int 2008; 19: 811-818. doi:10.1007/s00198-007-0506-x.
17. Suissa S. Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol 2008; 168: 329-335. doi:10.1093/aje/kwn135.
18. Campagna EJ, Muser E, Parks J, Morrato EH. Methodological considerations in estimating adherence and persistence for a long-acting injectable medication. J Manag Care Pharm 2014; 20: 756-766. Available at: http://www.ncbi.nlm.nih.gov/pubmed/24967528. Accessed August 5, 2014.
19. Long-term-care Homes - Medication Management. Office of the Auditor General of Ontario Annual Report 2007; 232-258.
20. Barlas S. New medicare part d rule affects long-term-care pharmacies. Pharm Ther 2011; 36: 319.
21. Rosenheck RA, Krystal JH, Lew R, et al. Long-acting risperidone and oral antipsychotics in unstable schizophrenia. N Engl J Med 2011; 364: 842-851. doi:10.1056/NEJMoa1005987.
22. Spreen WR, Margolis DA, Pottage JC. Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS 2013; 8: 565-571. doi:10.1097/COH.0000000000000002.
23. Gold DT, Martin BC, Frytak JR, Amonkar MM, Cosman F. A claims database analysis of persistence with alendronate therapy and fracture risk in post-menopausal women with osteoporosis. Curr Med Res Opin 2007; 23: 585-594. doi:10.1185/030079906X167615.
24. Mudd KE, Bollinger ME, Hsu VD, Manning A, Tsoukleris MG, Butz AM. Concordance of Medicaid and pharmacy record data in inner-city children with asthma. Contemp Clin Trials 2008; 29: 13-20. doi:10.1016/j.cct.2007.05.002.
25. Coates KS, Healy R, Morrison WR. Tracking the Snowbirds: Seasonal Migration from Canada to the U.S.A. and Mexico. Am Rev Can Stud 2002; 32: 433-450.
26. Marshall VW, Longino CF, Tucker R, Mullins L. Health care utilization of Canadian snowbirds: an example of strategic planning. J Aging Health 1989; 1: 150-168.